Exploring ethical considerations for the use of biological and physiological markers in population-based surveys in less developed countries

Globalization and Health

Adnan A Hyder¹  Gregory Pappas² 

[1] Assistant Professor, Dept. of International Health and Berman Bioethics Institute, Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD 21205, USA;Chairman, Department of Community Health Science, Aga Khan University, 3500 Stadium Road, Karachi, Pakistan

关键词: less developed countries;    ethical standards;    population based health surveys;   

Others  :  823174
DOI  :  10.1186/1744-8603-1-16

 received in 2005-04-06, accepted in 2005-11-28,  发布年份 2005

【 摘 要 】

Background

The health information needs of developing countries increasingly include population-based estimates determined by biological and physiological measures. Collection of data on these biomarkers requires careful reassessment of ethical standards and procedures related to issues of safety, informed consent, reporting, and referral policies. This paper reviews the survey practices of health examination surveys that have been conducted in developed nations and discusses their application to similar types of surveys proposed for developing countries.

Discussion

The paper contends that a unitary set of ethical principles should be followed for surveys around the world that precludes the danger of creating double standards (and implicitly lowers standards for work done in developing countries). Global ethical standards must, however, be interpreted in the context of the unique historical and cultural context of the country in which the work is being done. Factors that influence ethical considerations, such as the relationship between investigators in developed and developing countries are also discussed.

Summary

The paper provides a set of conclusions reached through this discussion and recommendations for the ethical use of biomarkers in populations-based surveys in developing countries.

【 授权许可】

   
2005 Pappas and Hyder; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Boerma J, Holt E, Black R: Measurement of Biomarkers in Surveys in Developing Countries: Opportunities and Problems. Popul Dev Rev 2001, 27(2):303-14.
• [2]Finch C, Vaupel J, Kinsella K, (Eds): Cells and Surveys: Should Biological Measures Be Included in Social Science Research? In Committee on Population. National Research Council National Academy Press: Washington DC; 2001.
• [3]Uzbekistan National Health Survey 2004. ORC Macro: Calverton, MD; 2004.
• [4]Dominican Republic Demographic and Health Survey 2002. ORC Marco: Calverton, MD; 2002.
• [5]Mali Demographic and Health Survey 2001. ORC Macro: Calverton, MD; 2001.
• [6]Biological and Clinical Data Collection in Population Surveys in Less Developed Countries Summary of a meeting held by MEASURE Evaluation National Academy of Sciences: January 24–25, 2000; Washington DC
• [7]London L: Ethical Oversight of Public Health Research: Can Rules and IRBs Make a Difference in Developing Countries? AJPH 2002, 92(7):1079-84.
• [8]CIOMS International Ethical Guidelines for Biomedical Research Involving Human Subjects [draft]. Geneva, Switzerland: Council of International Organizations of Medical Sciences (CIOMS); 2002.
• [9]Butler D: Call for North/South code of research ethics. Nature 2000, 406:337.
• [10]Tangwa GB: Moral Agency, Moral Worth and the Question of Double Standards in Medical Research in Developing Countries. Developing World Bioeth 2001, 1(2):156-162.
• [11]Fisher G, Pappas G, Limb M: Prospects Problems and Prerequisites for National Health Examination Surveys in Less Developed Countries. Soc Sci Med 1996, 42:1639-1650.
• [12]Wagener DK: Ethical considerations in the design and execution of the National and Hispanic Health and Nutrition Examination Survey (HANES). Environ Health Perspect 1995, 103(3):75-80.
• [13]Pakistan Medical Research Council: Health Profile of the People of Pakistan. Islamabad. 1997.
• [14]McQuillan G, Speers MA, Burt V: Applying the Federal Regulations for Protecting Human Subjects in Survey Research: The NHANES Experience [unpublished manuscript]. NBAC archive 2000.
• [15]Schulte , Hunter , Rothman : Ethical and Social Issues in the Use of Biomarkers in Epidemiologic Research. IARC Sci Publ 1997, 142:313-318.
• [16]Brody BA: Making informed consent meaningful. IRB 2001, 23:1-5.
• [17]Zion D, Gillam L, Loff B: The Declaration of Helsinki, CIOMS and the ethics of research on vulnerable populations. Nat Med 2000, 6:615-617.
• [18]64 FR 29321-29325: National Health and Nutrition Examination Survey Program DNA Specimens; guidelines. In Federal Register. Centers for Disease Control and Prevention; June 1, 1999
• [19]Castillo FA: Limiting Factors Impacting on Voluntary First Person Informed Consent in the Philippines. Developing World Bioeth 2002, 2(1):21-27.
• [20]Yoder , Stanley P, Konaté MK: Obtaining Informed Consent for HIV Testing: The DHS Experience in Mali. ORC Macro: Calverton, MD; 2002.
• [21]Findlay JS, Schaible WL: A Study of the Effect of Remuneration Upon Response in the Health and Nutrition Examination Survey. In Vital and Health Statistical Series 2. Washington DC: GPO; 1975:76-1341. [DHEN (Series Editor): No. 67]
• [22]Oonagh C: Empty ethics: the problem with informed consent. Sociol Health Illn 2003, 25(7):768-92.
• [23]Angell M: The ethics of clinical research in the Third World. N Engl J Med 1997, 337:847-849.
• [24]Smith CB, Battlin MP, Jacobson JA, et al.: Are there characteristics of Infectious Diseases that raise special ethical issues? Developing World Bioeth 2004, 4(1):1-16.
• [25]Macpherson CC: Searching for Consensus. Bioethics 2004, 18(3):283-292.